ESPR
Esperion Therapeutics Inc.
$2.53
-$0.13(-4.89%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$536.32M
Volume
6.54M
52W Range
$0.69 - $3.94
Target Price
$5.80
EPS Estimates Overview
| Current Quarter | $0.06 | Next Quarter | $0.06 |
| Current Year | $0.01 | Next Year | $0.03 |
| QoQ Growth | +0.0% | YoY Growth | +200.0% |
| 3Y EPS CAGR | +68.9% | Target Price | $5.80 |
| Consensus | Buy | Upside | +129.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ESPR | $2.53 | -4.9% | 6.54M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Esperion Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW